MedImmune announced that it has begun shipping FluMist (intranasal, live, attenuated influenza vaccine) to vaccine distributors who service healthcare providers. MedImmune expects to provide approximately 15 million doses of FluMist for the 2010–2011 influenza season.

FluMist is a trivalent, live, attenuated influenza virus vaccine in a nasal spray formulation indicated for active immunization of individuals 2–49 years of age against influenza virus types A and B. This season’s vaccine will include the 2009 H1N1 pandemic strain among the three vaccine strains.

For more information call (800) 949-3789 or visit